• No results found

[PDF] Top 20 Decreased Gait and Function in Duchenne Muscular Dystrophy

Has 10000 "Decreased Gait and Function in Duchenne Muscular Dystrophy" found on our website. Below are the top 20 most common "Decreased Gait and Function in Duchenne Muscular Dystrophy".

Decreased Gait and Function in Duchenne Muscular Dystrophy

Decreased Gait and Function in Duchenne Muscular Dystrophy

... The MFM provides a numerical measure of motor skills for patients with neuromuscular diseases. It compris- es 32 items, static and dynamic. These items are tested in lying, sitting or standing positions and are divided ... See full document

7

Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy

Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy

... Duchenne muscular dystrophy (DMD) is one of the most common inherited pediatric neuromuscular dis- orders, affecting 1 in 3,500 live male ...motor function [1,2]. Besides the impairment of ... See full document

6

Technological Tools for Observational Evaluation - the Experience with the Software for Functional Evaluation Scale for Duchenne Muscular Dystrophy – A Pilot Study Software for Observational Evaluation

Technological Tools for Observational Evaluation - the Experience with the Software for Functional Evaluation Scale for Duchenne Muscular Dystrophy – A Pilot Study Software for Observational Evaluation

... To describe the development and usability of a software that optimizes the application of the Functional Evaluation Scale for people with Duchenne muscular dystrophy[r] ... See full document

7

Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids

Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids

... ► Is the early use of non- invasive ventilation (NIV) in Duchenne muscular dystrophy (DMD) detrimental to lung function (LF) decline in Duchenne’s patients who are treated with long- [r] ... See full document

8

Effect of Combination L Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

Effect of Combination L Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

... motor function decline) at 26 weeks in favor of patients treated with combination therapy, this study did not demonstrate a statistically significant treatment ...muscle function observed among some young ... See full document

14

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy

... Becker muscular dys- trophy (BMD), which results in a much milder pheno- type, is mainly caused by mutations maintaining the open reading frame and allowing the production of a partially deleted but functional ... See full document

6

Modifying function and fibrosis of cardiac and skeletal muscle from mdx mice

Modifying function and fibrosis of cardiac and skeletal muscle from mdx mice

... Duchenne Muscular Dystrophy (DMD), an inherited neuromuscular disorder occurring in approximately 1 in 3500 live male births, is caused by lack of the membrane bound protein, ...cardiac ... See full document

251

How Respiratory Muscle Strength Correlates with Cough Capacity in Patients with Respiratory Muscle Weakness

How Respiratory Muscle Strength Correlates with Cough Capacity in Patients with Respiratory Muscle Weakness

... with Duchenne muscular dystrophy (DMD) were ...Pulmonary function tests including forced vital capacity (FVC) and respiratory muscle strength (maximal expiratory pressure, MEP; maximal ... See full document

6

Eteplirsen in the treatment of Duchenne muscular dystrophy

Eteplirsen in the treatment of Duchenne muscular dystrophy

... Abstract: Duchenne muscular dystrophy is a fatal neuromuscular disorder affecting around one in 3,500–5,000 male births that is characterized by progressive muscular ...in Duchenne ... See full document

13

Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy

Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy

... of Duchenne muscular dystrophy (DMD) continues to lead to improved physical and functional status, allowing increasingly successful transitions to independence and self-actualization in ...on ... See full document

19

Respiratory Management of the Patient With Duchenne Muscular Dystrophy

Respiratory Management of the Patient With Duchenne Muscular Dystrophy

... pulmonary function testing and, with their caregivers, be educated about assessing and managing respiratory ...pulmonary function over time (Fig 1).‍ Serial monitoring of pulmonary function is ... See full document

12

Recent advances in Duchenne muscular dystrophy

Recent advances in Duchenne muscular dystrophy

... Abstract: Duchenne muscular dystrophy (DMD), an allelic X-linked progressive muscle- wasting disease, is one of the most common single-gene disorders in the developed ... See full document

24

Decreased Gray Matter Concentration and Local Synchronization of Spontaneous Activity in the Motor Cortex in Duchenne Muscular Dystrophy

Decreased Gray Matter Concentration and Local Synchronization of Spontaneous Activity in the Motor Cortex in Duchenne Muscular Dystrophy

... found decreased glu- cose metabolism in patients with DMD in the right sensori- motor ...implicated decreased excitability in the left motor cortex in patients with DMD (n ⫽ ... See full document

5

Muscle activation during gait in children with Duchenne muscular dystrophy

Muscle activation during gait in children with Duchenne muscular dystrophy

... kinematic gait pattern of children with DMD has been suggested to be the result of the greater proximal than distal weakness, as well as the presence of muscle contrac- tures in the more advanced stages of the ... See full document

14

Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation

Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation

... taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular 587. dystrophy[r] ... See full document

26

Characterization of Cardiomyopathy in a Mouse Model of Duchenne Muscular Dystrophy (DMD) Using Echocardiography, DCE-CT, and PET-FDG

Characterization of Cardiomyopathy in a Mouse Model of Duchenne Muscular Dystrophy (DMD) Using Echocardiography, DCE-CT, and PET-FDG

... Duchenne muscular dystrophy (DMD) is an X-­‐linked recessive neuromuscular disease that is the result of a loss of functional dystrophin, which causes cardiomyocyte fibrosis and death, leading to ... See full document

76

Airway Clearance in Duchenne Muscular Dystrophy

Airway Clearance in Duchenne Muscular Dystrophy

... DMD have altered swallowing function to begin with, but through compensatory measures they are able to take in adequate calories for weight maintenance with- out aspiration. When their work of breathing increases ... See full document

7

A Transition Toolkit for Duchenne Muscular Dystrophy

A Transition Toolkit for Duchenne Muscular Dystrophy

... when function begins to be difficult and should be emphasized during middle and high school to identify devices that will make daily life more efficient or easy and that are also safe for bathing, toileting, ... See full document

10

Comprehensive genetic characteristics of dystrophinopathies in China

Comprehensive genetic characteristics of dystrophinopathies in China

... The database for dystrophinopathies we created is a registry containing a wealth of information about pa- tients with DMD/BMD, including mutation characteris- tics, family history, epidemiological data, natural history, ... See full document

10

Clinical Reasoning: A 33-year-old man with cardiomyopathy and myopathy

Clinical Reasoning: A 33-year-old man with cardiomyopathy and myopathy

... In our patient, the subacute onset of symptoms and lack of systemic illness argue against infectious etiology. He did not have skin lesions to suggest der- matomyositis. He had not been taking medications or consuming ... See full document

6

Show all 10000 documents...